StereoTactic radiotherapy for wet Age-Related macular degeneration (STAR): study protocol for a randomised controlled clinical trial-Reference-Cited by-同舟云学术

StereoTactic radiotherapy for wet Age-Related macular degeneration (STAR): study protocol for a randomised controlled clinical trial

Published:2016-11-24 Issue:1 Volume:17 Page:
ISSN:1745-6215
Container-title:Trials
language:en
Short-container-title:Trials

Author:

Neffendorf James E.,Desai Riti,Wang Yanzhong,Kelly Joanna,Murphy Caroline,Reeves Barnaby C.,Chakravarthy Usha,Wordsworth Sarah,Lewis Cornelius,Peacock Janet,Uddin Shahir,O’Sullivan Joe M.,Jackson Timothy L.

Funder

Efficacy and Mechanism Evaluation Programme

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Medicine (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1186/s13063-016-1676-7.pdf

Reference26 articles.

1. Klein R, Klein BE, Jensen SC, Mares-Perlman JA, Cruickshanks KJ, Palta M. Age-related maculopathy in a multiracial United States population: the National Health and Nutritional Examination Survey III. Ophthalmology. 1999;106(6):1056–65.

2. Owen CG, Jarrar Z, Wormald R, et al. The estimated prevalence and incidence of late stage age related macular degeneration in the UK. Br J Ophthalmol. 2012;96(5):752–6.

3. Brown DM, Kaiser PK, Michels M, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006;355(14):1432–44.

4. Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355(14):1419–31.

5. Amoaku WM, Chakravarthy U, Gale R, et al. Defining response to anti-VEGF therapies in neovascular AMD. Eye (Lond). 2015;29(6):721–31.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stereotactic radiotherapy for neovascular age-related macular degeneration (STAR): a pivotal, randomised, double-masked, sham-controlled device trial;The Lancet;2024-07

2. Real-world experience of using stereotactic radiotherapy combined with anti-vascular endothelial growth factor to treat neovascular AMD;Graefe's Archive for Clinical and Experimental Ophthalmology;2024-03-06

3. Evolution and Advances in Wet Age-Related Macular Degeneration Treatments;Advances in Ophthalmology and Optometry;2023-08

4. Vitrectomy, subretinal Tissue plasminogen activator and Intravitreal Gas for submacular haemorrhage secondary to Exudative Age-Related macular degeneration (TIGER): study protocol for a phase 3, pan-European, two-group, non-commercial, active-control, observer-masked, superiority, randomised controlled surgical trial;Trials;2022-01-31

5. In vitro evaluation of simulated stereotactic radiotherapy for wet age-related macular degeneration on three different cell lines;Scientific Reports;2021-04-13